Comparison of sedative and analgesic effect of Gabapentin and Dexmedetomidine
Phase 3
- Conditions
- Anxiety.Other mental disorders due to brain damage and dysfunction and to physical disease
- Registration Number
- IRCT2016011822794N2
- Lead Sponsor
- Vice Chancellor for research of Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Entry criterion:
Age between 18 and 65
ASA1, 2
Body mass index lower than 28 kg on stature product
Acquire written consent
Exit criterion:
Existence of records in a systemic malady (high blood pressure, all types of collagen disease, ischemic heart, kidney, digestive system and etc…), allergies records, contraindications of gabapentin and dexmedetomidine
Addiction to drugs and alcohol
Pregnancy
Paroxysmal
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety. Timepoint: 6 hours after intervention. Method of measurement: Ramsay scale.;Pain. Timepoint: 6 hours after intervention. Method of measurement: standard questionnaires VAS.
- Secondary Outcome Measures
Name Time Method Sleep without provocation. Timepoint: 6 hours after intervention. Method of measurement: Ramsay scale.